homocysteine has been researched along with Cardiac Rupture, Traumatic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bayrak, BB; Karabulut Bulan, O; Koroglu, P; Yanardag, R | 1 |
| Brasselet, C; Ducher, L; Durand, E; Elaerts, J; Garnotel, R; Gillery, P; Lafont, A; Metz, D; Perotin, S; Vitry, F | 1 |
1 trial(s) available for homocysteine and Cardiac Rupture, Traumatic
| Article | Year |
|---|---|
Prepercutaneous coronary intervention plasma homocysteine concentration is a useful predictor of angioplasty-induced myocardial damage.
Topics: Angioplasty; Atherosclerosis; Biomarkers; Female; Heart Injuries; Homocysteine; Humans; Male; Middle Aged; Myocardium | 2005 |
1 other study(ies) available for homocysteine and Cardiac Rupture, Traumatic
| Article | Year |
|---|---|
Metformin protects against diabetes-induced heart injury and dunning prostate cancer model.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Antioxidants; Cell Line, Tumor; Diabetes Mellitus, Experimental; Glutathione; Heart Injuries; Homocysteine; Lipid Peroxidation; Male; Metformin; Myocardium; Nitric Oxide; Oxidoreductases; Prostatic Neoplasms; Rats; Reactive Oxygen Species | 2021 |